GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aleafia Health Inc (GREY:ALEAF) » Definitions » Total Payout Ratio

ALEAF (Aleafia Health) Total Payout Ratio : 0.17 (As of Nov. 10, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Aleafia Health Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Aleafia Health's current Total Payout Ratio is 0.17.


Aleafia Health Total Payout Ratio Historical Data

The historical data trend for Aleafia Health's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aleafia Health Total Payout Ratio Chart

Aleafia Health Annual Data
Trend Jan12 Jan13 Jan14 Jan15 Jan16 Oct17 Dec18 Dec19 Dec20 Mar23
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.33 1.53 - 0.06 0.16

Aleafia Health Quarterly Data
Oct17 Jan18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Jun22 Sep22 Dec22 Mar23
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 1.26 - - -

Competitive Comparison of Aleafia Health's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aleafia Health's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aleafia Health's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aleafia Health's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Aleafia Health's Total Payout Ratio falls into.



Aleafia Health Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Aleafia Health's Total Payout Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 4.109 + 0) / -25.292
=0.16

Aleafia Health's Total Payout Ratio for the quarter that ended in Mar. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -8.807
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aleafia Health Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Aleafia Health's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aleafia Health Business Description

Traded in Other Exchanges
N/A
Address
85 Basaltic Road, Concord, ON, CAN, L4K 1G4
Aleafia Health Inc is a vertically integrated cannabis health and wellness company which owns three cannabis product and cultivation facilities where it produces a diverse portfolio of commercially high-margin derivative products including oils, capsules and sprays. The company operates national network of medical cannabis clinics and has seen over 60,000 patients to date.